Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for hyperactivity and attention difficulties in youngsters and individuals. In Canada, its distribution is strictly regulated by https://apolisdexamfetamineincan762768.iyublog.com/41813614/this-medication-in-canada-a-comprehensive-guide